Biogen Inc. expects to begin shipping the company’s newly approved Alzheimer’s drug Aduhelm in about two weeks and has prepared more than 900 healthcare centers for the intravenous infusion treatment.

The United Kingdom’s Medicines & Healthcare Products Regulatory Agency (MHRA) granted temporary authorization for emergency use to Pfizer and BioNTech for the companies’ mRNA vaccine BNT162b2, marking the first Western country EUA for a Covid-19 vaccine.

The U.S. Transportation Department (DOT) has made preparations to enable the “immediate mass shipment” of Covid-19 vaccines and completed all necessary regulatory measures.